Cell-based Gene Therapy May Offer Long-term Treatment for Hemophilia A, Mouse Study Suggests
Cell therapy with endothelial progenitor cells and stem cells genetically engineered to produce a functional clotting factor VIII…
Articles by Ana Pena, PhD
Hepatitis C Virus Is Major Predictor of Liver Cancer in Hemophilia, U.S. Inpatient Data Reveals
Past infection with the hepatitis C virus (HCV) is the major risk factor for hepatocellular…
Bypassing Agents Used for Hemophilia A May Also Benefit Children with Hemophilia B, Case Series Reports
Single or combination therapy with bypassing agents used for hemophilia A patients with inhibitors can be suitable treatment…
Liver Transplant Highly Benefits, But May Not Fully Cure, Hemophilia, Case Report Shows
A liver transplant can be live-saving for hemophilia patients, but may not always fully cure the disease, according…
BAY 94-9027 Shows Extended Duration in Hemophilia A Patients in Analysis of Trial Data
BAY 94‐9027, an investigational factor VIII replacement therapy being developed by Bayer…
Gene Therapy Injected Into Dog Muscle Fares Well in Hemophilia B Study
Gene therapy delivered to muscle was able to completely correct hemophilia B deficient blood clotting in a safe…